Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.

It is not clear whether prophylactic antiviral therapy is indicated to improve patient and graft survival in patients undergoing liver transplantation for chronic decompensated hepatitis C virus (HCV) infection.